Moreover, treatment of OVX mice with G-1 attenuates immune cell infiltration and atherosclerosis [168], suggesting that GPER1 activation may be a therapeutic approach to target the increased cardiovascular risk in postmenopausal women. The gene discussed is GPER1; the disease is atherosclerosis.